Hematology
The role of hematology at Penn Medicine
Hematology is the study of blood and its diseases. Some of these conditions are malignant (cancerous), while others are benign (noncancerous). Even benign blood disorders can cause serious complications without the right care.
Specialists called hematologists “blood doctors” lead a team of experts to provide the care you need. At the Penn Blood Disorders Center, we bring together a specialized group focused on benign blood disorders. We also work closely with the Abramson Cancer Center at Penn Medicine to treat some conditions, such as blood cancers (hematological malignancies).
Hematology and blood health
People travel to see us from across the Mid-Atlantic and beyond. While we offer the top care they seek, they tell us they also appreciate the environment we’ve created. We know blood disorders can feel challenging at times, so we’ve created a place where you can feel comfortable and supported.
What you can expect when you choose our center
- Welcoming expertise: Our doctors are leaders in the field of blood disorders. They publish influential papers, give talks worldwide, and serve in professional groups, such as the American Society of Hematology. They know, though, that the best care goes beyond expertise. They want your experience to feel comfortable, like a visit to your local doctor’s office.
- Thorough care: We have one of the largest, most complete hematology groups in the region. In addition to hematologists, our team includes nurses and other advanced practice providers, physical therapists, social workers, and a psychologist specializing in pain. A nurse coordinator serves as your main contact. We also partner with a range of other top Penn Medicine specialists.
- Flexibility: You can choose to get all your care at our center, seek a second opinion, or travel to us only for major checkups. We work with your local doctors to ensure you can receive day-to-day care closer to home if preferred.
- Innovation: We’re working to answer big questions about blood disorders and improve care. In addition to leading research, we participate in clinical trials to develop new treatments, including gene therapy.
Blood disorder specialties
Blood conditions we treat
- Bone marrow failure syndromes
- Hemochromatosis (Iron Overload)
- Hemophilia A
- Hemophilia B (Christmas Disease)
- Idiopathic thrombocytopenic purpura (ITP)
- Myeloproliferative disease
Our doctors
Our providers work with you to plan and deliver exceptional treatment and personalized care.
Locations
Our hospitals, multispecialty medical centers, pharmacies, labs and more offer outstanding, personalized care for patients all across the region.
Related articles
Patient stories
How pickleball (and Penn Medicine) saved one patient’s life
With teamwork and determination, specialists at Penn Medicine solved Ronnie Recchia’s life-threatening medical mystery and got him back in the game.
How future cures begin as ideas in laboratories
The successes of CAR T research show the importance of the cycle of science—sparking new ideas and clinical trials that give patients better options.
70-year-old bench press competitor tackles rare cancer
While receiving treatment at Penn for a rare cancer, bench press competitor Howard Aaron continued to make fitness an essential part of his life.
‘You won the lottery’: The very first CAR T cell patient
Bill Ludwig will forever be known as the first person successfully treated with a cellular therapy that kills cancer cells with his own immune system.
Improving care for patients with acute lymphocytic leukemia
A clinical trial gave Becky Yu access to treatment that would become the new standard of care for newly diagnosed acute lymphocytic leukemia.
A lifetime of worry eased with one infusion
After receiving gene therapy for hemophilia, a disease Curt Krouse had lived with for 57 years, his “life changed in 30 minutes.”
How pickleball (and Penn Medicine) saved one patient’s life
With teamwork and determination, specialists at Penn Medicine solved Ronnie Recchia’s life-threatening medical mystery and got him back in the game.
How future cures begin as ideas in laboratories
The successes of CAR T research show the importance of the cycle of science—sparking new ideas and clinical trials that give patients better options.
70-year-old bench press competitor tackles rare cancer
While receiving treatment at Penn for a rare cancer, bench press competitor Howard Aaron continued to make fitness an essential part of his life.
‘You won the lottery’: The very first CAR T cell patient
Bill Ludwig will forever be known as the first person successfully treated with a cellular therapy that kills cancer cells with his own immune system.
Improving care for patients with acute lymphocytic leukemia
A clinical trial gave Becky Yu access to treatment that would become the new standard of care for newly diagnosed acute lymphocytic leukemia.
A lifetime of worry eased with one infusion
After receiving gene therapy for hemophilia, a disease Curt Krouse had lived with for 57 years, his “life changed in 30 minutes.”